• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Computational modeling of PET imaging agents for vesicular acetylcholine transporter (VAChT) protein binding affinity: application of 2D-QSAR modeling and molecular docking techniques.用于囊泡乙酰胆碱转运体(VAChT)蛋白结合亲和力的正电子发射断层扫描(PET)成像剂的计算建模:二维定量构效关系(2D-QSAR)建模和分子对接技术的应用
In Silico Pharmacol. 2023 Apr 4;11(1):9. doi: 10.1007/s40203-023-00146-4. eCollection 2023.
2
A Multi-layered Variable Selection Strategy for QSAR Modeling of Butyrylcholinesterase Inhibitors.多层变量选择策略在丁酰胆碱酯酶抑制剂 QSAR 建模中的应用。
Curr Top Med Chem. 2020;20(18):1601-1627. doi: 10.2174/1568026620666200616142753.
3
3D QSAR study, synthesis, and in vitro evaluation of (+)-5-FBVM as potential PET radioligand for the vesicular acetylcholine transporter (VAChT).3D QSAR 研究、合成及 (+)-5-FBVM 作为囊泡型乙酰胆碱转运体 (VAChT) 潜在 PET 放射性配体的体外评价。
Bioorg Med Chem. 2010 Nov 1;18(21):7659-67. doi: 10.1016/j.bmc.2010.08.028. Epub 2010 Aug 17.
4
PET Imaging of Cholinergic Neurotransmission in Neurodegenerative Disorders.正电子发射断层扫描成像在神经退行性疾病中胆碱能神经传递的应用。
J Nucl Med. 2022 Jun;63(Suppl 1):33S-44S. doi: 10.2967/jnumed.121.263198.
5
Synthesis and evaluation of a new vesamicol analog o-[(11)C]methyl-trans-decalinvesamicol as a PET ligand for the vesicular acetylcholine transporter.一种新型囊泡乙酰胆碱转运体PET配体——邻-[(11)C]甲基-反式-十氢萘囊泡胺的合成与评价
Ann Nucl Med. 2016 Feb;30(2):122-9. doi: 10.1007/s12149-015-1039-6. Epub 2015 Nov 25.
6
Quick and efficient quantitative predictions of androgen receptor binding affinity for screening Endocrine Disruptor Chemicals using 2D-QSAR and Chemical Read-Across.使用二维定量构效关系和化学类推快速有效地预测雄激素受体结合亲和力,用于筛选内分泌干扰化学物质。
Chemosphere. 2022 Dec;309(Pt 1):136579. doi: 10.1016/j.chemosphere.2022.136579. Epub 2022 Sep 26.
7
Exploring structural requirements of imaging agents against Aβ plaques in Alzheimer's disease: a QSAR approach.探索用于阿尔茨海默病中针对β淀粉样蛋白斑块的成像剂的结构要求:一种定量构效关系方法。
Comb Chem High Throughput Screen. 2015;18(4):411-9. doi: 10.2174/1386207318666150305124225.
8
PET radioligands for the vesicular acetylcholine transporter (VAChT).用于囊泡乙酰胆碱转运体(VAChT)的 PET 配体。
Curr Top Med Chem. 2010;10(15):1569-83. doi: 10.2174/156802610793176846.
9
Kinetics modeling and occupancy studies of a novel C-11 PET tracer for VAChT in nonhuman primates.新型用于非人灵长类动物中囊泡乙酰胆碱转运体(VAChT)的C-11正电子发射断层显像(PET)示踪剂的动力学建模与占有率研究
Nucl Med Biol. 2016 Feb;43(2):131-9. doi: 10.1016/j.nucmedbio.2015.11.003. Epub 2015 Nov 7.
10
In Vivo and In Vitro Characteristics of Radiolabeled Vesamicol Analogs as the Vesicular Acetylcholine Transporter Imaging Agents.放射性标记的 Vesamicol 类似物作为囊泡乙酰胆碱转运蛋白成像剂的体内和体外特征。
Contrast Media Mol Imaging. 2018 Jun 13;2018:4535476. doi: 10.1155/2018/4535476. eCollection 2018.

引用本文的文献

1
Synthesis and in vitro evaluation of spirobenzovesamicols as potential C-PET tracer alternatives to [F]FEOBV for vesicular acetylcholine transporter (VAChT) imaging.螺环苯并维西酰胺类化合物作为用于囊泡乙酰胆碱转运体(VAChT)成像的潜在碳-正电子发射断层扫描(C-PET)示踪剂替代[F]FEOBV的合成及体外评价
EJNMMI Radiopharm Chem. 2025 Feb 2;10(1):7. doi: 10.1186/s41181-025-00327-w.

本文引用的文献

1
The Relevance of Goodness-of-fit, Robustness and Prediction Validation Categories of OECD-QSAR Principles with Respect to Sample Size and Model Type.《关于样本量和模型类型,OECD-QSAR 原则中拟合优度、稳健性和预测验证类别与》
Mol Inform. 2022 Nov;41(11):e2200072. doi: 10.1002/minf.202200072. Epub 2022 Jul 25.
2
First report of q-RASAR modeling toward an approach of easy interpretability and efficient transferability.首次报告 q-RASAR 建模,旨在实现易于解释和高效可迁移性的方法。
Mol Divers. 2022 Oct;26(5):2847-2862. doi: 10.1007/s11030-022-10478-6. Epub 2022 Jun 29.
3
In vivo vesicular acetylcholine transporter density in human peripheral organs: an [F]FEOBV PET/CT study.人体外周器官中囊泡乙酰胆碱转运体的体内密度:一项[F]FEOBV正电子发射断层显像/计算机断层扫描研究
EJNMMI Res. 2022 Apr 1;12(1):17. doi: 10.1186/s13550-022-00889-9.
4
AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models.AlphaFold 蛋白质结构数据库:用高精度模型极大地扩展蛋白质序列空间的结构覆盖范围。
Nucleic Acids Res. 2022 Jan 7;50(D1):D439-D444. doi: 10.1093/nar/gkab1061.
5
Highly accurate protein structure prediction with AlphaFold.利用 AlphaFold 进行高精度蛋白质结构预测。
Nature. 2021 Aug;596(7873):583-589. doi: 10.1038/s41586-021-03819-2. Epub 2021 Jul 15.
6
Sample-size dependence of validation parameters in linear regression models and in QSAR.线性回归模型和定量构效关系中验证参数的样本量依赖性。
SAR QSAR Environ Res. 2021 Apr;32(4):247-268. doi: 10.1080/1062936X.2021.1890208. Epub 2021 Mar 22.
7
Effect of Dataset Size and Train/Test Split Ratios in QSAR/QSPR Multiclass Classification.数据集大小和训练/测试分割比例对 QSAR/QSPR 多类分类的影响。
Molecules. 2021 Feb 19;26(4):1111. doi: 10.3390/molecules26041111.
8
How Precise Are Our Quantitative Structure-Activity Relationship Derived Predictions for New Query Chemicals?我们基于定量构效关系得出的针对新查询化学品的预测有多精确?
ACS Omega. 2018 Sep 19;3(9):11392-11406. doi: 10.1021/acsomega.8b01647. eCollection 2018 Sep 30.
9
Applicability Domain: A Step Toward Confident Predictions and Decidability for QSAR Modeling.适用域:迈向QSAR建模的可靠预测与可判定性的一步。
Methods Mol Biol. 2018;1800:141-169. doi: 10.1007/978-1-4939-7899-1_6.
10
The cholinergic system in the pathophysiology and treatment of Alzheimer's disease.胆碱能系统在阿尔茨海默病的病理生理学和治疗中的作用。
Brain. 2018 Jul 1;141(7):1917-1933. doi: 10.1093/brain/awy132.

用于囊泡乙酰胆碱转运体(VAChT)蛋白结合亲和力的正电子发射断层扫描(PET)成像剂的计算建模:二维定量构效关系(2D-QSAR)建模和分子对接技术的应用

Computational modeling of PET imaging agents for vesicular acetylcholine transporter (VAChT) protein binding affinity: application of 2D-QSAR modeling and molecular docking techniques.

作者信息

De Priyanka, Roy Kunal

机构信息

Drug Theoretics and Cheminformatics Laboratory, Department of Pharmaceutical Technology, Jadavpur University, Kolkata, 700032 India.

出版信息

In Silico Pharmacol. 2023 Apr 4;11(1):9. doi: 10.1007/s40203-023-00146-4. eCollection 2023.

DOI:10.1007/s40203-023-00146-4
PMID:37035236
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10073372/
Abstract

UNLABELLED

The neurotransmitter acetylcholine (ACh) plays a ubiquitous role in cognitive functions including learning and memory with widespread innervation in the cortex, subcortical structures, and the cerebellum. Cholinergic receptors, transporters, or enzymes associated with many neurodegenerative diseases, including Alzheimer's disease (AD) and Parkinson's disease (PD), are potential imaging targets. In the present study, we have developed 2D-quantitative structure-activity relationship (2D-QSAR) models for 19 positron emission tomography (PET) imaging agents targeted against presynaptic vesicular acetylcholine transporter (VAChT). VAChT assists in the transport of ACh into the presynaptic storage vesicles, and it becomes one of the main targets for the diagnosis of various neurodegenerative diseases. In our work, we aimed to understand the important structural features of the PET imaging agents required for their binding with VAChT. This was done by feature selection using a Genetic Algorithm followed by the Best Subset Selection method and developing a Partial Least Squares- based 2D-QSAR model using the best feature combination. The developed QSAR model showed significant statistical performance and reliability. Using the features selected in the 2D-QSAR analysis, we have also performed similarity-based chemical read-across predictions and obtained encouraging external validation statistics. Further, we have also performed molecular docking analysis to understand the molecular interactions occurring between the PET imaging agents and the VAChT receptor. The molecular docking results were correlated with the QSAR features for a better understanding of the molecular interactions. This research serves to fulfill the experimental data gap, highlighting the applicability of computational methods in the PET imaging agents' binding affinity prediction.

SUPPLEMENTARY INFORMATION

The online version contains supplementary material available at 10.1007/s40203-023-00146-4.

摘要

未标注

神经递质乙酰胆碱(ACh)在包括学习和记忆在内的认知功能中发挥着普遍作用,在皮层、皮层下结构和小脑中广泛分布。与包括阿尔茨海默病(AD)和帕金森病(PD)在内的许多神经退行性疾病相关的胆碱能受体、转运体或酶是潜在的成像靶点。在本研究中,我们针对19种靶向突触前囊泡乙酰胆碱转运体(VAChT)的正电子发射断层扫描(PET)成像剂开发了二维定量构效关系(2D-QSAR)模型。VAChT有助于将ACh转运到突触前储存囊泡中,它成为各种神经退行性疾病诊断的主要靶点之一。在我们的工作中,我们旨在了解PET成像剂与VAChT结合所需的重要结构特征。这是通过使用遗传算法进行特征选择,然后采用最佳子集选择方法,并使用最佳特征组合开发基于偏最小二乘法的2D-QSAR模型来实现的。所开发的QSAR模型显示出显著的统计性能和可靠性。利用在2D-QSAR分析中选择的特征,我们还进行了基于相似性的化学类推预测,并获得了令人鼓舞的外部验证统计数据。此外,我们还进行了分子对接分析,以了解PET成像剂与VAChT受体之间发生的分子相互作用。分子对接结果与QSAR特征相关联,以便更好地理解分子相互作用。本研究有助于填补实验数据空白,突出了计算方法在PET成像剂结合亲和力预测中的适用性。

补充信息

在线版本包含可在10.1007/s40203-023-00146-4获取的补充材料。